Latest AI and machine learning research in hemophilia for healthcare professionals.
BACKGROUND: Sunitinib resistance remains a major clinical challenge in renal cell carcinoma, and the...
Nucleic acid therapeutics offer promise for precision cancer treatment, but are limited by inaccurat...
Intestinal barrier breakdown is a key driver of sepsis-related multiple organ dysfunction; however, ...
Immune checkpoint inhibitors (ICIs) have substantially improved clinical outcomes across multiple ma...
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with limited effective disease-mo...
Chitin synthase is a fungal-specific and highly selective antifungal target, and its inhibitors repr...
While effective against non-small cell lung cancer (NSCLC), PD-1 inhibitors can induce immune-relate...
Tyrosyl-DNA phosphodiesterase I (TDP1) repairs topoisomerase I (TOP1)-mediated DNA damage and is a p...
Glycogen synthase kinase-3β (GSK3β) is a serine/threonine kinase involved in neurodegenerative, neur...
Machine learning (ML) models integrating genetic and clinical data show promise for personalizing an...
Interferon-inducible RNA-dependent protein kinase (PKR) is an emerging therapeutic target involved i...
The selection of a donor for allogeneic hematopoietic stem cell transplantation (HSCT) is a complex,...
BACKGROUND: Anthrax remains a life-threatening zoonotic disease in resource-limited settings. Adsorb...
BACKGROUND: Tumor microenvironment (TME) including stromal composition and antitumor immune response...
INTRODUCTION: Infection is a common and potentially fatal complication during the treatment of hemat...
BACKGROUND: Diffuse Gastric Cancer (DGC) is an aggressive subtype with a poor prognosis and a lack o...
Malaria, caused by Plasmodium falciparum is a deadly disease and remains a global health concern. Wi...
INTRODUCTION: The combination of CDK4/6 inhibitors and endocrine therapy is the first-line standard ...
Lung adenocarcinoma (LUAD) exhibits considerable heterogeneity and therapeutic resistance. Here, we ...
Deep mutational scanning (DMS) has proven effective for mapping protein-protein interactions (PPIs),...
BACKGROUND: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) are standard therapy for HR+/HER2 - me...